<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/cc1495.anc" start="1459" end="1466" sStart="-1" offset="0" sid="null" wn="2147483645" wnkey="null" text="We studied 50 patients undergoing elective coronary artery bypass surgery, following approval from the local ethics committee and once &lt;b&gt;written&lt;/b&gt; informed consent had been obtained from each patient." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1495.anc" start="7960" end="7966" sStart="null" offset="22" sid="r11.severe.j.0459" wn="5" wnkey="severe%5:00:00:critical:03" text="In a few cases it was severe and spread all over the body surface." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1495.anc" start="9191" end="9201" sStart="null" offset="46" sid="r11.recommend.v.0554" wn="1" wnkey="recommend%2:32:01::" text="For this reason, the international literature recommends that vancomycin be infused over a period of 60 min in order to prevent these side effects, and hypotension in particular, which in some cases manifests as life-threatening shock [ 6, 8, 9, 16]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/cc1495.anc" start="2345" end="2352" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="After the monitoring devices had been positioned (electrocardiograph leads DII-V5 for ST-segment analysis; radial artery cannula and pulmonary artery catheter [Arrow AH 050050-H, 7.5 F; Arrow International, Inc., &lt;b&gt;Reading&lt;/b&gt;, PA, USA] transcuta-neous oxygen saturation probe), vancomycin (15 mg/kg) was administered at a constant rate by a syringe pump (DPS Fre-senius; Grenoble, France) over 30 min." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1495.anc" start="1784" end="1790" sStart="null" offset="255" sid="r9.normal.j.0177" wn="1" wnkey="normal%3:00:01::" text="Admission criteria to the study were as follows: stable preoperative haemodynamic conditions, no intravenous cardiovascular therapy, no preoperative diuretic therapy, sinus rhythm, no history of anaphylactic reactions, and normal hepatic and renal function." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1495.anc" start="13604" end="13610" sStart="null" offset="167" sid="r9.normal.j.0113" wn="3" wnkey="normal%3:00:03::" text="The degree of reduction in PaO 2 was moderate and had no important impact on arterial haemostasis in the patients studied, who showed however normal preoperative respiratory function." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1495.anc" start="11652" end="11656" sStart="null" offset="31" sid="r7.1.face.n.0044" wn="2147483647" wnkey="null" text="The stability of heart rate in face of a reduction in systemic vascular resistance in group A patients renders possible an influence of preoperative ?-blocker therapy on haemodynamic compensation." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1495.anc" start="8452" end="8456" sStart="null" offset="127" sid="r7.1.face.n.0229" wn="1" wnkey="human_face%1:08:01::" text="It generally appears alone, but sometimes it is associated with headache; flushing; erythematous rash over the face, neck and upper torso (the so-called 'red man' syndrome); hypotension; and broncospasm [ 4, 13, 14, 15]." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1495.anc" start="14644" end="14651" sStart="null" offset="5" sid="r11.benefit.n.0976" wn="2" wnkey="benefit%1:07:00::" text="This benefit is useful not so much in intensive care units (where patients are continuously and adequately monitored) as in medical and surgical departments overall, where monitoring of arterial pressure is not continuous and nurse care is not as strict as in the intensive care unit." />
  </sentences>
</list>